Cargando…

Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study

Treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors may have pleiotropic and beneficial effects in terms of ameliorating of risk factors for the progression of autosomal dominant polycystic kidney disease (ADPKD). However, there is insufficient evidence regarding the use of these drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morioka, Fumiyuki, Nakatani, Shinya, Uedono, Hideki, Tsuda, Akihiro, Mori, Katsuhito, Emoto, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573882/ https://www.ncbi.nlm.nih.gov/pubmed/37834985 http://dx.doi.org/10.3390/jcm12196341

Ejemplares similares

Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
por: Nakatani, Shinya, et al.
Publicado: (2021)

Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients
por: Nakatani, Shinya, et al.
Publicado: (2020)

New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report
por: Nakatani, Shinya, et al.
Publicado: (2022)

Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
por: Morioka, Fumiyuki, et al.
Publicado: (2022)

Association between Serum Zinc and Calcification Propensity (T(50)) in Patients with Type 2 Diabetes Mellitus and In Vitro Effect of Exogenous Zinc on T(50)
por: Nakatani, Shinya, et al.
Publicado: (2020)

Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells
por: Uedono, Hideki, et al.
Publicado: (2021)

Seronegative Full-house Nephropathy with Crohn's Disease
por: Uedono, Hideki, et al.
Publicado: (2022)

Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects – study of inulin and para-aminohippuric acid clearance in humans
por: Yasumoto, Mari, et al.
Publicado: (2015)

Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients
por: Nakatani, Shinya, et al.
Publicado: (2018)

Association of Zinc Deficiency with Development of CVD Events in Patients with CKD
por: Nakatani, Shinya, et al.
Publicado: (2021)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort
por: Nakaya, Rino, et al.
Publicado: (2022)

Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry
por: Kurajoh, Masafumi, et al.
Publicado: (2019)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives ~
por: Morioka, Tomoaki, et al.
Publicado: (2021)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial
por: Iseki, Kunitoshi, et al.
Publicado: (2022)

A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease
por: Sorohan, Bogdan Marian, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Association between Levocarnitine Treatment and the Change in Knee Extensor Strength in Patients Undergoing Hemodialysis: A Post-Hoc Analysis of the Osaka Dialysis Complication Study (ODCS)
por: Matsufuji, Shota, et al.
Publicado: (2022)

Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
por: Ochi, Akinobu, et al.
Publicado: (2014)

Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis
por: Mori, Katsuhito, et al.
Publicado: (2019)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
por: Ishimoto, Yu, et al.
Publicado: (2017)

Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort
por: Yamazaki, Yuko, et al.
Publicado: (2021)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Bilateral emphysematous pyelonephritis in autosomal dominant polycystic kidney disease
por: Lakshminarayana, G., et al.
Publicado: (2012)

Autosomal Dominant Polycystic Kidney Disease: 2009 Update for Internists
por: Bennett, William M.
Publicado: (2009)

Urine proteome of autosomal dominant polycystic kidney disease patients
por: Bakun, Magda, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_032opkpc0rkanuh7hee9vs2r1i